[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614897":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":27,"locations":36,"responsibleParty":49,"collaborators":20,"id":51,"slug":20,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":20,"enrollmentInfo":59,"targetDuration":20,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":38,"whyStopped":20,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Centre Henri Becquerel","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental","EXPERIMENTAL","PET\u002FCT of the specimen after surgery",[13],"Device: micro PET\u002FCT",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","micro PET\u002FCT","PET\u002FT of the speciment after surgery",[9],null,[22,25],{"name":23,"affiliation":5,"role":24},"Sebastien Hapdey, PhD","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":5,"role":24},"Lise-Marie Roussel, MD",[28,32],{"name":26,"role":29,"phone":30,"phoneExt":20,"email":31},"CONTACT","+33232082222","lise-marie.roussel@chb.unicancer.fr",{"name":33,"role":29,"phone":34,"phoneExt":20,"email":35},"Doriane Richard, PhD","+33232082985","doriane.richard@chb.unicancer.fr",[37],{"facility":5,"status":38,"city":39,"state":20,"zip":20,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Rouen","France",{"type":42,"coordinates":43},"Point",[44,45],1.09932,49.44313,{"lat":45,"lon":44},[48],{"name":26,"role":29,"phone":30,"phoneExt":20,"email":31},{"type":50,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100614897",false,"NCT07285564","Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer","TEP Margins","Inclusion Criteria:\n\n* Signed informed consent\n* Adult, male or female, aged 18 or over\n* Patient with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, regardless of lymph node status (any N) M0, operable\n* Member or beneficiary of a social security plan\n\nExclusion Criteria:\n\n* Child-Pugh C liver failure\n* Patients under guardianship, conservatorship, or legal protection\n* Patients deprived of their liberty\n* Pregnant or breastfeeding women\n* Hypersensitivity to 18F-FDG or any of its excipients (ethanol or water for injection)\n* Uncontrolled diabetes\n* Moderate to end-stage renal failure, stage IIIB to V (glomerular filtration rate less than 44 mL\u002Fmin\u002F1.73 m²)\n* Patients unable to understand the study for any reason or to comply with the trial requirements (language, psychological, or geographical issues).","ALL","18 Years",{"count":60,"type":61},10,"ESTIMATED","INTERVENTIONAL",[64],"NA","The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).",[67],"Head & Neck Cancer",[69,70,71],"Margins","microPET\u002FCT","specimen","2025-12-02",{"date":74,"type":75},"2025-12-16","ACTUAL",{"date":77,"type":75},"2025-11-07",{"date":79,"type":61},"2026-06-15",{"name":5,"class":6},1]